Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 6.8e-05 | 1 |